Skip to main content
. 2026 Jan 7;18(1):80. doi: 10.3390/pharmaceutics18010080
AGAT Arginine–glycine amidinotransferase
ALS Amyotrophic lateral sclerosis
ALSFRS-R Amyotrophic lateral sclerosis functional rating scale (revised)
AUC Area under the curve
ATP Adenosine triphosphate
BBB Blood–brain barrier
BCRP Breast cancer resistance protein
CMC Chemistry, Manufacturing, and Controls
CNS Central nervous system
CrT Creatine transporter
CrTD Creatine transporter deficiency
CSF Cerebrospinal fluid
DCE Dodecyl creatine ester
DHA Docosahexaenoic acid
DTE Drug targeting efficiency
DTP Direct NtB percentage
EEG Electroencephalogram
fMRI Functional MRI
GAMT Guanidinoacetate methyltransferase
GLUT Glucose transporter
GRAS Generally recognized as safe
GSPR General safety and performance requirement
iDDC Integral drug-device combination
IN Intranasal
IV Intravenous
LFP Local field potential
MCT Monocarboxylate transporter
MDR Medical device regulation
MRI Magnetic resonance imaging
MRP Multidrug resistance-associated protein
NHP Non-human primate
NOAEL No observed adverse effect level
NORD National Organization for Rare Disorders
NtB Nose-to-brain
NtN Nose-to-neurons
PBPK Physiologically based pharmacokinetic modelling
P-gp P-glycoprotein
PEG Polyethylene glycol
PSD Particle size distribution
PET Positron emission tomography
qEEG Quantitative EEG
SPECT Single photon emission computed tomography
WGA Wheat germ agglutinin